References
- GOODNICK PJ: Ziprasidone: profile on safety. Expert Opin. Pharmacother. (2001) 2(10):1655–1662.
- CITROME L, JOSIASSEN R, BARK N, BROWN KS, MALLIKAARJUN S, SALAZAR DE: Pharmacokinetics and safety of aripiprazole and concomitant mood stabilizers. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002): Abstract NR317.
- YEUNG P, MCQUADE RD, CARSON WH, SAHA A, ALT MW, INGENITO G: Aripiprazole and risperidone versus placebo in schizophrenia. Ear: Psychiatry (2002) 17\(Suppl. 1):102–103.
- LIEBERMAN JA, CARSON WH, SAHA AR et al: Meta-analysis of the efficacy of aripiprazole in schizophrenia. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002):Abstract NR353.
- KUJAWA M, SAHA A, INGENITO GG, ALI M, LUO X, ARCHIBALD DG: Aripiprazole for long-term maintenance treatment of schizophrenia. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002):Abstract NR376.
- PIGOTT TA, SAHA AR, ALT MW et al: Aripiprazole versus placebo in the treatment of stable, chronic schizophrenia. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002):Abstract NR 351.
- KECK PE, SAHA A, IWAMOTO T et al: Aripiprazole versus placebo in acute mania. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002):Abstract NR314.
- CASEY DE, SAHA A, ALT M, JODY D, KUJAWA M, STOCK E, INGENITO GG: Switching to aripiprazole monotherapy. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002):Abstract NR310.
- MAGUIRE GA: Prolactin elevation with antipsychotic medication: mechanism of action and clinical consequences. J. Clin. Psychiatry (2002) 63\(Suppl. 4):56–62.
- CARSON WH, STOCK E, SAHA AR, ALT MW, MCQUADE RD, KUJAWA MJ, INGENITO G: Safety and tolerability meta-analysis in schizophrenia. Eur. Psychiatry (2002) 17\(Suppl. 1):106.
- JODY D, SAHA A, IWAMOTO T et al: Meta-analysis of weight effects with aripiprazole. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002):Abstract NR367.
- GOODNICK PJ, JERRY J, PAPA F: Psychotropic drugs and the ECG: focus on the QT c Interval. Expert Opin. Pharmacother. (2002) 3(5):479–498.
- STOCK E, SAHA A, BRUNELL R, ARCHIBALD DG, IWAMOTOT, MCQUADE RD: Meta-analysis of cardiac safety with aripiprazole. American Psychiatric Association Annual Meeting. Philadelphia, PA, USA (2002) Abstract NR364.